NCT01650987已完成不适用
Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- Toxicities including on sexual function
研究概览
简要总结
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
详细描述
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients whose treatment is provided to Centre Oscar Lambret
- •With a corpus uteri adenocarcinoma, no metastatic, treated by:
- •Surgery and observation without complementary treatment
- •Or surgery and adjuvant radiotherapy
- •Or Surgery and curietherapy of vaginal dome
- •With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- •External radiochemotherapy and curietherapy
- •Or only surgery
- •Or pre-surgical curietherapy and surgery
- •Age > 18 years
排除标准
- 未提供
结局指标
主要结局
Toxicities including on sexual function
时间窗: up to 3 years
According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary
次要结局
- Compare the various scales of toxicity(up to 3 years)
- Study the sexual behavior modifications(up to 3 years)
- Specify correlation modifications of sexual behavior(up to 3 years)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Endothelial Progenitor Cells in Cervical Cancer Patients Receiving ChemoradiationCervical CancerNCT00753610Mackay Memorial Hospital30
尚未招募
Unknown
life expectancy in cervical cancer patients after treatment.CTRI/2024/02/062998J prasanthi
招募中
2 期
Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix CancerCervix Uteri CancerNCT04831437Tehran University of Medical Sciences60
已完成
不适用
Predicting Outcome in Cervix Carcinoma: a Prospective StudyCervical CancerNCT01825005Maastricht Radiation Oncology423
已完成
不适用
Sparing of Organs at Risk in High Dose Rate BrachytherapyCervical Carcinoma Stage IB to IVNCT01681342Centre Oscar Lambret24